Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Claggett

Showing results (231-240 of 362) with videos related to

Pageof 37
Sort By:
Cardiovascular Diabetology|June 18, 2022
Effects of sacubitril/valsartan on glycemia in patients with diabetes and heart failure: the PARAGON-HF and PARADIGM-HF trialsMagnus O Wijkman, Brian Claggett, Muthiah Vaduganathan, et al.
Nature Cardiovascular Research|August 28, 2024
Author Correction: Apparent risks of postural orthostatic tachycardia syndrome diagnoses after COVID-19 vaccination and SARS-Cov-2 InfectionAlan C Kwan, Joseph E Ebinger, Janet Wei, et al.
Nature Cardiovascular Research|June 12, 2023
Apparent Risks of Postural Orthostatic Tachycardia Syndrome Diagnoses After COVID-19 Vaccination and SARS-Cov-2 InfectionAlan C Kwan, Joseph E Ebinger, Janet Wei, et al.
Journal of the American Heart Association|February 8, 2022
Flu Vaccine and Mortality in Hypertension: A Nationwide Cohort StudyDaniel Modin, Brian Claggett, Mads Emil Jørgensen, et al.
Circulation. Heart Failure|October 26, 2018
IGFBP7 (Insulin-Like Growth Factor-Binding Protein-7) and Neprilysin Inhibition in Patients With Heart FailureJames L Januzzi, Milton Packer, Brian Claggett, et al.
Circulation. Heart Failure|March 11, 2016
Impact of Spironolactone on Longitudinal Changes in Health-Related Quality of Life in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist TrialEldrin F Lewis, Hae-Young Kim, Brian Claggett, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 4, 2014
Assessment of myocardial viability and left ventricular function in patients supported by a left ventricular assist deviceDeepak K Gupta, Hicham Skali, Jose Rivero, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 21, 2016
C-Reactive Protein and Risk of ESRD: Results From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)Finnian R Mc Causland, Brian Claggett, Emmanuel A Burdmann, et al.
JACC. Heart Failure|December 27, 2016
Race-Related Differences in Left Ventricular Structural and Functional Remodeling in Response to Increased Afterload: The ARIC StudyMiguel M Fernandes-Silva, Amil M Shah, Sheila Hegde, et al.
Journal of the American College of Cardiology|October 6, 2018
Genetic Variants in SGLT1, Glucose Tolerance, and Cardiometabolic RiskSara B Seidelmann, Elena Feofanova, Bing Yu, et al.
Pageof 37

Showing results (231-240 of 362) with videos related to

Sort By:
Pageof 37
Cardiovascular Diabetology|June 18, 2022
Effects of sacubitril/valsartan on glycemia in patients with diabetes and heart failure: the PARAGON-HF and PARADIGM-HF trialsMagnus O Wijkman, Brian Claggett, Muthiah Vaduganathan, et al.
Nature Cardiovascular Research|August 28, 2024
Author Correction: Apparent risks of postural orthostatic tachycardia syndrome diagnoses after COVID-19 vaccination and SARS-Cov-2 InfectionAlan C Kwan, Joseph E Ebinger, Janet Wei, et al.
Nature Cardiovascular Research|June 12, 2023
Apparent Risks of Postural Orthostatic Tachycardia Syndrome Diagnoses After COVID-19 Vaccination and SARS-Cov-2 InfectionAlan C Kwan, Joseph E Ebinger, Janet Wei, et al.
Journal of the American Heart Association|February 8, 2022
Flu Vaccine and Mortality in Hypertension: A Nationwide Cohort StudyDaniel Modin, Brian Claggett, Mads Emil Jørgensen, et al.
Circulation. Heart Failure|October 26, 2018
IGFBP7 (Insulin-Like Growth Factor-Binding Protein-7) and Neprilysin Inhibition in Patients With Heart FailureJames L Januzzi, Milton Packer, Brian Claggett, et al.
Circulation. Heart Failure|March 11, 2016
Impact of Spironolactone on Longitudinal Changes in Health-Related Quality of Life in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist TrialEldrin F Lewis, Hae-Young Kim, Brian Claggett, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 4, 2014
Assessment of myocardial viability and left ventricular function in patients supported by a left ventricular assist deviceDeepak K Gupta, Hicham Skali, Jose Rivero, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 21, 2016
C-Reactive Protein and Risk of ESRD: Results From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)Finnian R Mc Causland, Brian Claggett, Emmanuel A Burdmann, et al.
JACC. Heart Failure|December 27, 2016
Race-Related Differences in Left Ventricular Structural and Functional Remodeling in Response to Increased Afterload: The ARIC StudyMiguel M Fernandes-Silva, Amil M Shah, Sheila Hegde, et al.
Journal of the American College of Cardiology|October 6, 2018
Genetic Variants in SGLT1, Glucose Tolerance, and Cardiometabolic RiskSara B Seidelmann, Elena Feofanova, Bing Yu, et al.
Pageof 37